 Survival Rate
"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 L01.280.975.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 0 | 1 | 1 | | 1989 | 0 | 4 | 4 | | 1990 | 0 | 12 | 12 | | 1991 | 0 | 16 | 16 | | 1992 | 0 | 11 | 11 | | 1993 | 0 | 14 | 14 | | 1994 | 0 | 32 | 32 | | 1995 | 0 | 37 | 37 | | 1996 | 0 | 24 | 24 | | 1997 | 0 | 34 | 34 | | 1998 | 0 | 44 | 44 | | 1999 | 0 | 31 | 31 | | 2000 | 0 | 39 | 39 | | 2001 | 0 | 31 | 31 | | 2002 | 0 | 32 | 32 | | 2003 | 1 | 32 | 33 | | 2004 | 0 | 32 | 32 | | 2005 | 0 | 31 | 31 | | 2006 | 0 | 37 | 37 | | 2007 | 0 | 27 | 27 | | 2008 | 0 | 57 | 57 | | 2009 | 0 | 48 | 48 | | 2010 | 0 | 75 | 75 | | 2011 | 0 | 71 | 71 | | 2012 | 0 | 60 | 60 | | 2013 | 1 | 61 | 62 | | 2014 | 0 | 67 | 67 | | 2015 | 0 | 57 | 57 | | 2016 | 0 | 60 | 60 | | 2017 | 0 | 57 | 57 | | 2018 | 0 | 39 | 39 | | 2019 | 0 | 63 | 63 | | 2020 | 0 | 7 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
Sacconi A, Donzelli S, Pulito C, Ferrero S, Spinella F, Morrone A, Rigoni M, Pimpinelli F, Ensoli F, Sanguineti G, Pellini R, Agrawal N, Izumchenko E, Ciliberto G, Giannì A, Muti P, Strano S, Blandino G. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients. J Exp Clin Cancer Res. 2020 Sep 23; 39(1):200.
-
Rogers HJ, Wang X, Xie Y, Davis AR, Thakral B, Wang SA, Borthakur G, Cantu MD, Margolskee EM, Philip JKS, Sukhanova M, Bagg A, Bueso-Ramos CE, Orazi A, Arber DA, Hsi ED, Hasserjian RP. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study. Am J Hematol. 2020 07; 95(7):799-808.
-
Gupta P, Dhull AK, Kaushal V. A comparative study of concomitant boost radiation versus concomitant boost with concurrent chemoradiation versus standard fractionation chemoradiation in locally advanced head-and-neck cancer. J Cancer Res Ther. 2020 Apr-Jun; 16(3):478-484.
-
Shelby RD, Suarez-Kelly LP, Yu PY, Hughes TM, Ethun CG, Tran TB, Poultsides G, King DM, Bedi M, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Howard JH, Cardona K, Grignol V. Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. J Surg Oncol. 2020 Jun; 121(8):1249-1258.
-
Kaplon AW, Galloway TJ, Bhayani MK, Liu JC. Effect of HPV Status on Survival of Oropharynx Cancer with Distant Metastasis. Otolaryngol Head Neck Surg. 2020 08; 163(2):372-374.
-
Holoubek SA, Yan H, Kuchta KM, Winchester DJ, Moo-Young TA, Prinz RA. Trends in nonoperative management of papillary thyroid microcarcinoma. J Surg Oncol. 2020 May; 121(6):952-957.
-
Suh E, Stratton KL, Leisenring WM, Nathan PC, Ford JS, Freyer DR, McNeer JL, Stock W, Stovall M, Krull KR, Sklar CA, Neglia JP, Armstrong GT, Oeffinger KC, Robison LL, Henderson TO. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol. 2020 03; 21(3):421-435.
-
Perkins JD, Dick AA, Healey PJ, Montenovo MI, Biggins SW, Sibulesky L, Reyes JD. New Evidence Supporting Increased Use of Split Liver Transplantation. Transplantation. 2020 02; 104(2):299-307.
-
Ferguson MK, Mitzman B, Derstine B, Lee SM, Pienta MJ, Wang SC, Lin J. A Morphomic Index Is an Independent Predictor of Survival After Lung Cancer Resection. Ann Thorac Surg. 2020 03; 109(3):873-878.
-
Geoerger B, Kang HJ, Yalon-Oren M, Marshall LV, Vezina C, Pappo A, Laetsch TW, Petrilli AS, Ebinger M, Toporski J, Glade-Bender J, Nicholls W, Fox E, DuBois SG, Macy ME, Cohn SL, Pathiraja K, Diede SJ, Ebbinghaus S, Pinto N. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020 01; 21(1):121-133.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|